The diagnostic accuracy of OCT angiography in naive and treated neovascular age-related macular degeneration: a review

被引:43
|
作者
Perrott-Reynolds, Rhianon [1 ]
Cann, Robert [2 ]
Cronbach, Nicola [3 ]
Neo, Yan Ning [4 ]
Ho, Vivian [5 ]
McNally, Orla [6 ]
Madi, Haifa A. [7 ]
Cochran, Claire [8 ]
Chakravarthy, Usha [9 ,10 ]
机构
[1] Univ Hosp Wales, Dept Ophthalmol, Cardiff CF14 4XW, S Glam, Wales
[2] Mid Yorkshire Hosp NHS Trust, Wakefield WF1 4DG, W Yorkshire, England
[3] Buckinghamshire Healthcare NHS trust, Oxford, England
[4] Hillingdon Hosp NHS Trust, Uxbridge UB8 3NN, Middx, England
[5] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Liverpool L14 3LB, Merseyside, England
[6] Belfast Hlth & Social Care Trust, Belfast BT9 7AB, Antrim, North Ireland
[7] Sunderland Eye Infirm, Sunderland SR2 9HP, Tyne & Wear, England
[8] Univ Aberdeen, EDNA Study Team, Aberdeen AB25 2ZD, Scotland
[9] Queens Univ Belfast, Ophthalmol & Vis Sci, Belfast BT7 1NN, Antrim, North Ireland
[10] Belfast Hlth & Social Care Trust, Dept Ophthalmol, Belfast BT9 7AB, Antrim, North Ireland
关键词
COHERENCE TOMOGRAPHY ANGIOGRAPHY; CHOROIDAL NEOVASCULARIZATION; TYPE-3; NEOVASCULARIZATION;
D O I
10.1038/s41433-018-0229-6
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Optical coherence tomography angiography (OCTA) is a non-invasive retinal imaging innovation that has been gaining popularity for the evaluation of the retinal vasculature. Of clinical importance is its current use either as an alternative or in conjunction with conventional dye-based angiography in neovascular age-related macular degeneration. OCTA is not without limitations and these include image artefact, a relatively small field of view and failure of the segmentation algorithms, which can confound the interpretation of findings. While there are numerous publications on OCTA in neovascular AMD, few have examined the diagnostic accuracy of this new technology compared with the accepted gold standard of fundus fluorescein angiography (FFA). In this review, we summarise the literature on the clinical application of OCTA in nAMD. In particular, we have reviewed the published articles that have reported the sensitivity and specificity of OCTA in the diagnosis of nAMD, and those that have described and or correlated the morphological findings and compared them to dye-based angiography.
引用
收藏
页码:274 / 282
页数:9
相关论文
共 50 条
  • [21] Review of Neovascular Age-Related Macular Degeneration Treatment Options
    Holekamp, Nancy M.
    AMERICAN JOURNAL OF MANAGED CARE, 2019, 25 (07): : S172 - S181
  • [22] OCT-A in neovascular age related macular degeneration
    Lumbroso, B.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [23] Macular translocation for neovascular age-related macular degeneration
    Eandi, Chiara M.
    Giansanti, Fabrizio
    Virgili, Gianni
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (04):
  • [24] High dose aflibercept treatment in naive neovascular age-related macular degeneration
    Acar, Nur
    Pehlivanoglu, Seren
    INTERNATIONAL OPHTHALMOLOGY, 2025, 45 (01)
  • [25] Structural Bscan OCT correlation with OCT angiography biomarkers of activity in neovascular age related macular degeneration
    Ambresin, A.
    Mantel, I.
    Bergin, C.
    Naso, S.
    ACTA OPHTHALMOLOGICA, 2017, 95
  • [26] Microperimetric changes in neovascular age-related macular degeneration treated with ranibizumab
    Alexander, P.
    Mushtaq, F.
    Osmond, C.
    Amoaku, W.
    EYE, 2012, 26 (05) : 678 - 683
  • [27] Microperimetric changes in neovascular age-related macular degeneration treated with ranibizumab
    P Alexander
    F Mushtaq
    C Osmond
    W Amoaku
    Eye, 2012, 26 : 678 - 683
  • [28] Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration
    Hang, Abraham
    Ngo, Taylor
    Virk, Jaipreet Singh
    Moussa, Kareem
    Moshiri, Ala
    Emami-Naeini, Parisa
    Park, Susanna S.
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 3781 - 3789
  • [29] Ranibizumab for neovascular age-related macular degeneration
    Rosenfeld, Philip J.
    Brown, David M.
    Heier, Jeffrey S.
    Boyer, David S.
    Kaiser, Peter K.
    Chung, Carol Y.
    Kim, Robert Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14): : 1419 - 1431
  • [30] Pegaptanib for neovascular age-related macular degeneration
    Gragoudas, ES
    Adamis, AP
    Cunningham, ET
    Feinsod, M
    Guyer, DR
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27): : 2805 - 2816